olmesartan has been researched along with Coronary Artery Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirohata, A; Ito, H; Komatsubara, I; Kusachi, S; Miyoshi, T; Murakami, T; Nakamura, K; Ohe, T; Usui, S; Yamamoto, K | 1 |
| Amano, T; Harada, K; Ichimiya, S; Ishii, H; Kanashiro, M; Kobayashi, M; Kurebayashi, N; Marui, N; Murohara, T; Sone, T; Suzuki, S; Tsuboi, H; Uetani, T; Yoshikawa, D | 1 |
| Miura, S; Saku, K | 1 |
| Aoki, J; Hara, K; Hashimoto, T; Isshiki, T; Kozuma, K; Nakajima, Y; Tanabe, K; Tanimoto, S; Yahagi, K | 1 |
| Matrosova, IB; Mel'nikova, EA; Oleĭnikov, VÉ | 1 |
| Hatanaka, K; Hina, K; Hirohata, A; Hirohata, S; Hirose, E; Ishizawa, M; Kawamura, H; Komatsubara, I; Kusachi, S; Miyoshi, T; Murakami, M; Murakami, T; Ohe, T; Ohkawa, K; Sato, S; Yamaji, H; Yamamoto, K; Yamawaki, H | 1 |
| Marso, SP | 1 |
| Hatanaka, K; Hirohata, A; Hirohata, S; Hirose, E; Ito, H; Kobayashi, Y; Komatsubara, I; Kusachi, S; Miyoshi, T; Ohara, M; Ohe, T; Ohkawa, K; Sano, F; Takafuji, H; Toyama, Y; Yamamoto, K; Yamawaki, H | 1 |
1 review(s) available for olmesartan and Coronary Artery Disease
| Article | Year |
|---|---|
Recent progress in the treatment of cardiovascular disease using olmesartan.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Coronary Artery Disease; Coronary Stenosis; Disease Models, Animal; Humans; Hypertension; Imidazoles; Plaque, Atherosclerotic; Tetrazoles | 2014 |
5 trial(s) available for olmesartan and Coronary Artery Disease
| Article | Year |
|---|---|
Olmesartan reduces inflammatory biomarkers in patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the OLIVUS trial.
Topics: Adiponectin; Aged; Angina, Stable; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Coronary Vessels; Disease Progression; Down-Regulation; Female; Humans; Imidazoles; Inflammation Mediators; Japan; Male; Middle Aged; Percutaneous Coronary Intervention; Plaque, Atherosclerotic; Prospective Studies; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2014 |
Impact of angiotensin II receptor blocker therapy (olmesartan or valsartan) on coronary atherosclerotic plaque volume measured by intravascular ultrasound in patients with stable angina pectoris.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coronary; Angiotensin II Type 1 Receptor Blockers; Combined Modality Therapy; Coronary Artery Disease; Disease Progression; Double-Blind Method; Female; Humans; Hypertension; Image Interpretation, Computer-Assisted; Imidazoles; Long-Term Care; Male; Middle Aged; Tetrazoles; Ultrasonography, Interventional; Valine; Valsartan | 2013 |
[Corrective effect of olmesartan on parameters of the local rigidity using the echo-tracking technology].
Topics: Adult; Antihypertensive Agents; Carotid Arteries; Carotid Intima-Media Thickness; Coronary Artery Disease; Drug Monitoring; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Reproducibility of Results; Tetrazoles; Treatment Outcome; Vascular Stiffness | 2014 |
Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Disease Progression; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Imidazoles; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Survival Rate; Tetrazoles; Ultrasonography, Interventional | 2010 |
Four-year clinical outcomes of the OLIVUS-Ex (impact of Olmesartan on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) extension trial.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Angiotensin II Type 1 Receptor Blockers; Cerebrovascular Disorders; Chi-Square Distribution; Coronary Artery Disease; Disease Progression; Disease-Free Survival; Female; Heart Diseases; Humans; Imidazoles; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2012 |
2 other study(ies) available for olmesartan and Coronary Artery Disease
| Article | Year |
|---|---|
Effect of olmesartan on the levels of circulating endothelial progenitor cell after drug-eluting stent implantation in patients receiving statin therapy.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Endothelial Progenitor Cells; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Male; Percutaneous Coronary Intervention; Postoperative Period; Tetrazoles | 2014 |
Plaque burden with composition? That is the next question.
Topics: Aged; Angioplasty, Balloon, Coronary; Angiotensin II Type 1 Receptor Blockers; Combined Modality Therapy; Coronary Artery Disease; Coronary Vessels; Disease Progression; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Imidazoles; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Survival Analysis; Tetrazoles; Ultrasonography, Interventional | 2010 |